Merck-AstraZeneca breast cancer drug reduces risk of death by 28% in patients diagnosed early, clinical trial shows
About 87.5% of patients treated with the drug were alive after six years, compared to 83.2% who received a placebo.
About 87.5% of patients treated with the drug were alive after six years, compared to 83.2% who received a placebo.
AI can spot patterns in the data from blood tests that can give an early warning of disease.
Surgeries will be financially rewarded if patients with long term conditions see the same GP each time.
Emily Handstock says she feels the pain women endure has been "normalised" by society.
Hospice leaders had warned they were being forced to close beds closing due to financial pressures.
Public-health experts are calling for minimum pricing to stop further rises in harmful drinking.
"Serious failings" are found at the NHS trust that treated Nottingham attacker Valdo Calocane.
Hospitals say they often struggle to recover costs, particularly when patients return overseas.
Jodee Seeley tells BBC Newsnight she is considering legal action against Great Ormond Street Hospital.